Science and Research

Rapid Ascent to 4559 m Is Associated with Increased Plasma Components of the Vascular Endothelial Glycocalyx and May Be Associated with Acute Mountain Sickness

Background: The stress of high altitude alters vascular permeability, which may be related to structural changes in the endothelial glycocalyx. We aimed to study these changes by measuring plasma concentrations of several glycocalyx components upon exposure to high altitude. Methods: Plasma collected from 17 subjects at low altitude (423 m) and at three time points (7, 20, and 44 hours) after rapid ascent to high altitude (4559 m) were evaluated for concentrations of three glycocalyx components: syndecan-1, intercellular adhesion molecule-1 (ICAM-1), and heparan sulfate. Vital signs and echocardiographic measurement of systolic pulmonary artery pressure (sPAP) and cardiac output were also obtained at low and high altitudes. Results: Mean age of the study population was 35.5 ± 11.2 years with a body mass index of 22.7 ± 2.5 kg/m(2). Concentrations of ICAM-1 and heparan sulfate increased from baseline to 7 hours after arrival at high altitude; the ICAM-1 rise persisted at 20 hours. Syndecan-1 concentrations were increased only at 44 hours. Increased ICAM-1 concentrations correlated with sPAP and peripheral edema. Elevations in heparan sulfate appeared to correlate with acute mountain sickness (AMS). Conclusions: Levels of circulating glycocalyx components increase after exposure to high altitude and may correlate with AMS. Measuring plasma concentrations of various glycocalyx components could serve as a useful tool for further evaluation of vascular endothelial injury and repair in illness at high altitude.

  • Swenson, K. E.
  • Berger, M. M.
  • Sareban, M.
  • Macholz, F.
  • Schmidt, P.
  • Schiefer, L. M.
  • Mairbäurl, H.
  • Swenson, E. R.

Keywords

  • Acute Disease
  • Adult
  • Altitude
  • *Altitude Sickness
  • Endothelium, Vascular
  • *Glycocalyx
  • Humans
  • Middle Aged
  • Plasma
  • Young Adult
  • *icam-1
  • *acute mountain sickness
  • *altitude
  • *heparan sulfate
  • *syndecan-1
Publication details
DOI: 10.1089/ham.2019.0081
Journal: High Alt Med Biol
Pages: 176-183 
Number: 2
Work Type: Original
Location: TLRC
Disease Area: PH
Partner / Member: UKHD
Access-Number: 32182144

DZL Engagements

chevron-down